Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
11
NMPA:11
Drug Approvals
Desmopressin Oral Solution
- Product Name
- 去氨加压素口服溶液
- Approval Number
- 国药准字H20253512
- Approval Date
- Mar 4, 2025
NMPA
Ambroxol Hydrochloride Drops
- Product Name
- 盐酸氨溴索滴剂
- Approval Number
- 国药准字H20244867
- Approval Date
- Sep 10, 2024
NMPA
Rupatadine Fumarate Tablets
- Product Name
- 富马酸卢帕他定片
- Approval Number
- 国药准字H20243053
- Approval Date
- Jan 16, 2024
NMPA
Pregabalin Oral Solution
- Product Name
- 普瑞巴林口服溶液
- Approval Number
- 国药准字H20233864
- Approval Date
- Dec 22, 2023
NMPA
Levocetirizine Dihydrochloride Oral Drops
- Product Name
- 盐酸左西替利嗪口服滴剂
- Approval Number
- 国药准字H20223143
- Approval Date
- Mar 16, 2022
NMPA
Desloratadine Citrate Disodium Capsules
- Product Name
- 枸地氯雷他定胶囊
- Approval Number
- 国药准字H20173031
- Approval Date
- Nov 14, 2021
NMPA
Desloratadine Citrate Disodium
- Product Name
- 枸地氯雷他定
- Approval Number
- 国药准字H20173022
- Approval Date
- Nov 8, 2021
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found